INVO Fertility, Inc (NASDAQ:IVF) Short Interest Update

INVO Fertility, Inc (NASDAQ:IVF) saw a significant drop in short interest in February. As of February 13th, there was short interest totaling 284,595 shares, a drop of 19.7% from the January 29th total of 354,428 shares. Based on an average daily trading volume, of 425,821 shares, the days-to-cover ratio is presently 0.7 days. Approximately 4.1% of the shares of the stock are short sold. Approximately 4.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 425,821 shares, the days-to-cover ratio is presently 0.7 days.

INVO Fertility Trading Down 6.5%

Shares of IVF traded down $0.06 on Tuesday, reaching $0.87. 379,627 shares of the company’s stock were exchanged, compared to its average volume of 10,548,115. The business has a 50 day moving average price of $1.08 and a two-hundred day moving average price of $3.84. INVO Fertility has a 12 month low of $0.71 and a 12 month high of $103.82. The stock has a market capitalization of $6.06 million, a P/E ratio of 0.00 and a beta of 2.66.

Analyst Ratings Changes

Separately, Maxim Group set a $4.00 target price on shares of INVO Fertility in a research report on Tuesday, February 10th. One research analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $4.00.

Institutional Investors Weigh In On INVO Fertility

A hedge fund recently bought a new stake in INVO Fertility stock. Citadel Advisors LLC bought a new stake in INVO Fertility, Inc (NASDAQ:IVF) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 66,849 shares of the company’s stock, valued at approximately $51,000. Citadel Advisors LLC owned 1.19% of INVO Fertility at the end of the most recent quarter. 12.02% of the stock is currently owned by institutional investors.

About INVO Fertility

INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.

The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation.